FDA posts Carbaglu briefing documents

FDA posted briefing documents ahead of Wednesday's Endocrinologic and Metabolic Drugs Advisory Committee meeting to discuss an NDA from Recordati S.p.A. (Milan:REC) for Carbaglu carglumic acid to trea...